ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2α/VEGF signaling

Dalin He1, Lei Li2, Guodong Zhu1

  • 1Sex Hormone Research Center, Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Cancer Research
|June 14, 2014
PubMed

Insights

Men develop more kidney cancer (renal cell carcinoma, RCC) than women. This study found that the androgen receptor (AR) activates a HIF2α/VEGF pathway, driving RCC progression and offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Urology

Background:

  • Renal cell carcinoma (RCC) exhibits a higher incidence in males compared to females.
  • The underlying biological mechanisms for this observed gender disparity remain largely unknown.

Purpose of the Study:

  • To investigate the role of the androgen receptor (AR) in driving renal cell carcinoma (RCC) progression.
  • To elucidate the molecular signaling pathways involved in AR-mediated RCC development.
  • To identify potential therapeutic targets for mitigating gender-specific RCC progression.

Main Methods:

  • Utilized in vitro and in vivo models of RCC to assess the impact of AR modulation on cancer cell behavior.
  • Investigated the effects of AR attenuation and augmentation on RCC cell proliferation, migration, and invasion.
  • Analyzed the modulation of HIF2α/VEGF signaling at both mRNA and protein levels in response to AR targeting.
  • Evaluated the efficacy of HIF2α/VEGF inhibitors and the AR degradation enhancer ASC-J9 in suppressing RCC progression.

Main Results:

  • Androgen receptor (AR) activity was found to induce a HIF2α/VEGF signaling pathway crucial for RCC progression.
  • Modulation of AR levels significantly affected RCC cell proliferation, migration, and invasion in various experimental models.
  • Targeting AR inhibited RCC cell migration and invasion by regulating HIF2α/VEGF signaling at the molecular level.
  • Inhibition of HIF2α or VEGF, as well as the AR degrader ASC-J9, effectively suppressed RCC progression in vitro and in vivo.

Conclusions:

  • Discovered a novel role for the androgen receptor (AR) in the initiation and progression of renal cell carcinoma (RCC).
  • The AR-induced HIF2α/VEGF signaling pathway represents a critical mechanism underlying male predominance in RCC.
  • These findings suggest promising novel therapeutic strategies targeting the AR-HIF2α/VEGF axis for RCC treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K